The High "Cost" of Experimental Drugs Obtained Through Health Litigation in Brazil

• Κύριοι συγγραφείς: Ricardo Eccard da Silva (Συγγραφέας), Elisangela da Costa Lima (Συγγραφέας), Maria Rita C. G. Novaes (Συγγραφέας), Claudia G. S. Osorio- (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

BackgroundBrazilian patients have legal right to access unlicensed medicines undergoing clinical research, if there is evidence of efficacy and safety. This study investigated the occurrence of serious adverse events related to very high-cost medicines from clinical studies, expanded access and comp...